Metraipolis › archive › dc_edc463a28f3a

Targeting the BCL2 Family: Advances and Challenges in BH3 Mimetic-Based Therapies — Europe PMC PMID:41155156

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155156
DOI
10.3390/ijms26209859
License (as archived)
solo-consultazione
Archived
2026-11-09T09:55:53.966Z
SHA-256 of the archived text
f60052a52d2726fb5d4624d87b9de3af5752b7254d8dff2dfedfef1eeb21f7dd
Stable URL of this page
https://metraipolis.com/documento/dc_edc463a28f3a

How to cite

Targeting the BCL2 Family: Advances and Challenges in BH3 Mimetic-Based Therapies — Europe PMC PMID:41155156 — Europe PMC (en), https://europepmc.org/article/MED/41155156 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_edc463a28f3a (Metraipolis archive dc_edc463a28f3a, sha256 f60052a52d2726fb5d4624d87b9de3af5752b7254d8dff2dfedfef1eeb21f7dd)
BibTeX
@misc{dcedc463a28f3a,
  title = {Targeting the BCL2 Family: Advances and Challenges in BH3 Mimetic-Based Therapies — Europe PMC PMID:41155156},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155156},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_edc463a28f3a; sha256 f60052a52d2726fb5d4624d87b9de3af5752b7254d8dff2dfedfef1eeb21f7dd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155156. Agents can read the archived copy with the MCP tool read_document.